| Ident. | Authors (with country if any) | Title |
|---|
| 000163 (2016) |
Musleh A. Algarni [Canada] ; A Jon Stoessl [Canada] | The role of biomarkers and imaging in Parkinson's disease. |
| 000255 (2016) |
Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada] | Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. |
| 000260 (2016) |
Andrew D. Robertson [Canada] ; Michelle A. Messner [Canada] ; Zahra Shirzadi [Canada] ; Galit Kleiner-Fisman [Canada] ; Joyce Lee [Canada] ; Julia Hopyan [Canada] ; Anthony E. Lang [Canada] ; Sandra E. Black [Canada] ; Bradley J. Macintosh [Canada] ; Mario Masellis [Canada] | Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. |
| 000284 (2016) |
Enkhjargal Bayarsaikhan [Corée du Sud, Mongolie] ; Delger Bayarsaikhan [Corée du Sud] ; Jaesuk Lee [Corée du Sud] ; Myeongjoo Son [Corée du Sud] ; Seyeon Oh [Corée du Sud] ; Jeongsik Moon [Corée du Sud] ; Hye-Jeong Park [Corée du Sud] ; Arivazhagan Roshini [Corée du Sud] ; Seung U. Kim [Canada] ; Byoung-Joon Song [États-Unis] ; Seung-Mook Jo [Corée du Sud] ; Kyunghee Byun [Corée du Sud] ; Bonghee Lee [Corée du Sud] | Microglial AGE-albumin is critical for neuronal death in Parkinson’s disease: a possible implication for theranostics |
| 000425 (2016) |
Josie-Anne Bertrand [Canada] ; Anthony R. Mcintosh [Canada] ; Ronald B. Postuma [Canada] ; Natasha Kovacevic [Canada] ; Véronique Latreille [Canada] ; Michel Panisset [Canada] ; Sylvain Chouinard [Canada] ; Jean-François Gagnon [Canada] | Brain Connectivity Alterations Are Associated with the Development of Dementia in Parkinson's Disease. |
| 000468 (2015) |
Lorraine V. Kalia [Canada] ; Suneil K. Kalia | α-Synuclein and Lewy pathology in Parkinson's disease. |
| 000508 (2015) |
Jackalina M. Van Kampen [Canada] ; David C. Baranowski [Canada] ; Harold A. Robertson [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay [Canada] | The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease |
| 000599 (2015) |
Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada] | Parkinson's disease. |
| 000637 (2015) |
Yiming Xiao [Canada] ; Vladimir Fonov ; Silvain Bériault ; Fahd Al Subaie ; M Mallar Chakravarty ; Abbas F. Sadikot ; G Bruce Pike ; D Louis Collins | Multi-contrast unbiased MRI atlas of a Parkinson's disease population. |
| 000647 (2015) |
Helen Ling [Royaume-Uni] ; Yasmine T. Asi [Royaume-Uni] ; Igor N. Petrovic [Royaume-Uni] ; Zeshan Ahmed [Royaume-Uni] ; L K Prashanth [Canada] ; Lili-Naz Hazrati [Canada] ; Masatoyo Nishizawa [Japon] ; Tetsutaro Ozawa [Japon] ; Anthony Lang [Canada] ; Andrew J. Lees [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] | Minimal change multiple system atrophy: an aggressive variant? |
| 000678 (2015) |
Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni] | Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| 000690 (2015) |
Sarah Coakeley [Canada] ; Antonio P. Strafella [Canada] | Imaging pathological tau in atypical parkinsonian disorders |
| 000802 (2015) |
Hélène Doucet-Beaupré [Canada] ; Siew-Lan Ang [Royaume-Uni] ; Martin Lévesque [Canada] | Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b. |
| 000804 (2015) |
Grace Lee [Canada] ; Adrian C. Byram [Canada] ; Adrian M. Owen [Canada] ; Urs Ribary [Canada] ; A Jon Stoessl [Canada] ; Andrea Townson [Canada] ; Christine Stables [Canada] ; Judy Illes [Canada] | Canadian perspectives on the clinical actionability of neuroimaging in disorders of consciousness. |
| 000832 (2015) |
Paula Garcia-Esparcia [Espagne] ; Karina Hernández-Ortega [Espagne] ; Anusha Koneti [Espagne] ; Laura Gil [Espagne] ; Raul Delgado-Morales [Espagne] ; Ester Casta O [Espagne] ; Margarita Carmona [Espagne] ; Isidre Ferrer [Espagne] | Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson’s disease |
| 000849 (2015) |
Daryl J. Wile [Canada] ; Katie Dinelle [Canada] ; Nasim Vafai [Canada] ; Jessamyn Mckenzie [Canada] ; Joseph K. Tsui [Canada] ; Paul Schaffer [Canada] ; Yu-Shin Ding [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada] | A Scan Without Evidence Is Not Evidence of Absence: Scans Without Evidence of Dopaminergic Deficit in a Symptomatic Leucine-Rich repeat Kinase 2 Mutation Carrier |
| 000A51 (2014) |
Cecilia Vitali [Italie] ; Cheryl L. Wellington [Canada] ; Laura Calabresi [Italie] | HDL and cholesterol handling in the brain. |
| 000B32 (2014) |
Quentin Noirhomme [Belgique] ; Damien Lesenfants [Belgique] ; Francisco Gomez [Colombie] ; Andrea Soddu [Canada] ; Jessica Schrouff [Belgique, États-Unis] ; Gaëtan Garraux [Belgique] ; André Luxen [Belgique] ; Christophe Phillips [Belgique] ; Steven Laureys [Belgique] | Biased binomial assessment of cross-validated estimation of classification accuracies illustrated in diagnosis predictions |
| 000B37 (2014) |
Saeid Ghavami [Canada] ; Shahla Shojaei [Iran] ; Behzad Yeganeh [Canada] ; Sudharsana R. Ande [Canada] ; Jaganmohan R. Jangamreddy [Suède] ; Maryam Mehrpour [France] ; Jonas Christoffersson [Suède] ; Wiem Chaabane [Tunisie] ; Adel Rezaei Moghadam [Iran] ; Hessam H. Kashani [Canada] ; Mohammad Hashemi [Iran] ; Ali A. Owji [Iran] ; Marek J. Łos [Suède] | Autophagy and apoptosis dysfunction in neurodegenerative disorders. |
| 000B40 (2014) |
Shraddha Sapkota [Canada] ; Myrlene Gee ; Jennifer Sabino ; Derek Emery ; Richard Camicioli | Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease. |
| 000C35 (2013) |
Pettarusp M. Wadia [Inde] ; Peter Howard ; Manuel Q. Ribeirro ; Jennifer Robblee ; Abena Asante ; David J. Mikulis ; Anthony E. Lang | The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders. |
